Welcome to the BriaCell Therapeutics Corp. Annual General Meeting Reschedule

Important Announcement! Mark Your Calendars!

Hey there cancer-fighting superheroes! We’ve got some exciting news for you. BriaCell Therapeutics Corp. has announced a rescheduling of the Annual General Meeting of Shareholders. Originally set for January 23, 2025, the new date is February 5, 2025. So, clear your schedules and get ready for an eventful day!

Why the Change?

Now, you might be wondering why the sudden shift in plans. Well, blame it on the postal service snafu in Canada. Those pesky delays have forced us to push back the meeting to ensure that all our shareholders have ample time to participate. We want to hear from each and every one of you, so mark your calendars and be there on February 5th!

Where to Meet?

So, where’s the party happening? Well, we’ll be gathering at Suite 3400, One First Canadian Place, Toronto, ON, M5X 1A4. Be there bright and early at 9:00 a.m. (ET) to kick off the meeting with a bang!

What’s the Record Date?

Don’t worry, the record date remains the same – December 9, 2024. So, if you couldn’t make it to the original meeting, you still have a chance to be a part of the rescheduled event. We’re counting on your valuable input and support!

What Does This Mean for Me?

For shareholders, this rescheduled meeting provides an additional opportunity to be actively involved in the decision-making processes of the company. It allows for more time to prepare and submit proxies, ensuring that your voice is heard and considered in the discussions and resolutions that will take place during the meeting.

What Does This Mean for the World?

In a broader context, the rescheduling of the Annual General Meeting highlights the importance of adaptability and flexibility in the face of unforeseen circumstances. It underscores the need for companies to prioritize effective communication and engagement with their stakeholders, even in the midst of challenges such as postal service disruptions. By taking proactive steps to ensure shareholder participation and input, companies can foster a culture of transparency, accountability, and collaboration that ultimately benefits not only their stakeholders but also the larger community and industry as a whole.

Conclusion

In conclusion, the rescheduling of the Annual General Meeting of Shareholders by BriaCell Therapeutics Corp. is a testament to the company’s commitment to inclusivity, communication, and shareholder engagement. By extending the deadline and providing ample time for shareholders to participate, the company is demonstrating its dedication to transparency, accountability, and collaboration. So, mark your calendars, gear up for a productive meeting, and let your voice be heard on February 5, 2025!